Northeast Investment Management / JNJ
Northeast Investment Management’s Johnson & Johnson Position
Does Northeast Investment Management own Johnson & Johnson (JNJ)? Yes — 170.3K shares worth $42M (+1.72% of its 13F portfolio) as of Q1 2026, down from 172.5K shares the prior filed quarter.
Position Value
$42M
Q1 2026
Shares
170.3K
% of Portfolio
+1.72%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 170.3K | $42M | +1.72% |
| Q4 2025 | 172.5K | $36M | +1.39% |
| Q3 2025 | 172.2K | $32M | +1.29% |
| Q2 2025 | 174.2K | $27M | +1.14% |
| Q1 2025 | 176.0K | $29M | +1.36% |
| Q4 2024 | 180.4K | $26M | +1.16% |
| Q3 2024 | 189.0K | $31M | +1.37% |
| Q2 2024 | 189.6K | $28M | +1.30% |
| Q1 2024 | 196.0K | $31M | +1.52% |
| Q4 2023 | 196.9K | $31M | +1.65% |
| Q3 2023 | 198.8K | $31M | +1.82% |
| Q2 2023 | 214.2K | $35M | +2.00% |
| Q1 2023 | 218.2K | $34M | +2.05% |
| Q4 2022 | 221.1K | $39,049 | +2.49% |
| Q3 2022 | 223.7K | $37M | +2.47% |
| Q2 2022 | 225.9K | $40M | +2.56% |
| Q1 2022 | 224.8K | $40M | +2.10% |
| Q4 2021 | 223.2K | $38M | +1.86% |
| Q3 2021 | 226.5K | $37M | +1.95% |
| Q2 2021 | 224.5K | $37M | +1.99% |
| Q1 2021 | 225.7K | $37M | +2.19% |
| Q4 2020 | 225.1K | $35M | +2.16% |
| Q3 2020 | 225.1K | $34M | +2.23% |
| Q2 2020 | 222.7K | $31M | +2.34% |
| Q1 2020 | 220.4K | $29M | +2.65% |
| Q4 2019 | 227.3K | $33M | +2.44% |
| Q3 2019 | 231.7K | $30M | +2.40% |
| Q2 2019 | 238.3K | $33M | +2.64% |
| Q1 2019 | 235.5K | $33M | +2.76% |
| Q4 2018 | 236.5K | $31M | +2.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Northeast Investment Management’s full portfolio or all institutional holders of JNJ.